M
The FTC wants Martin Shkreli held in contempt.
According to the regulator, the so-called “Pharma Bro” hasn’t been complying with its investigation into whether his new company, Druglike, Inc, violates his ban from working in the pharmaceutical industry. A press release calls Druglike “a Web3 drug discovery software platform,” which definitely seems like something the world needs.
FTC Asks Federal Court to Hold ‘Pharma Bro’ Martin Shkreli in Contempt
[Federal Trade Commission]
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- Good riddance, Cybertruck!
- Anker’s new window-mounted camera monitors the outside of your home from within it
- I’ve reviewed almost every Android foldable this year — here’s how the iPhone Duo compares
- Why a new report on Anthropic automating AI development is alarming researchers
- KPop Demon Hunters on 4K Blu-ray costs less than a month of Netflix Premium
